Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects

Edward S Schelegle, W. C. Adams, A. D. Siefkin

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

We studied whether O3-induced pulmonary function decrements could be inhibited by the prostaglandin synthetase inhibitor, indomethacin, in healthy human subjects. Fourteen college-age males completed six 1-h exposure protocols consisting of no drug, placebo, and indomethacin (Indocin SR 75 mg every 12 h for 5 days) pretreatments, with filtered air and O3 (0.35 ppm) exposures within each pretreatment. Pretreatments were delivered weekly in random order in a double-blind fashion. Ozone and filtered air exposures, separated by 72 h, were delivered in random order in a single-blind fashion. Exposures consisted of 1-h exercise on a bicycle ergometer with work loads set to elicit a mean minute ventilation of 60 L/min. Statistical analysis revealed significant (p < 0.05) across pretreatment effects for FVC and FEV1, with no drug versus indomethacin and placebo versus indomethacin comparisons being significant. These findings suggest that cyclooxygenase products of arachidonic acid, which are sensitive to indomethacin inhibition, play a prominent role in the development of pulmonary function decrements consequent to acute O3 exposure.

Original languageEnglish (US)
Pages (from-to)1350-1354
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume136
Issue number6
StatePublished - 1987

Fingerprint

Ozone
Indomethacin
Lung
Prostaglandin-Endoperoxide Synthases
Air
Placebos
Prostaglandin Antagonists
Workload
Pharmaceutical Preparations
Ventilation
Healthy Volunteers
Exercise

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects. / Schelegle, Edward S; Adams, W. C.; Siefkin, A. D.

In: American Review of Respiratory Disease, Vol. 136, No. 6, 1987, p. 1350-1354.

Research output: Contribution to journalArticle

@article{4862396a68ba46f8935c1ce8d5353d19,
title = "Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects",
abstract = "We studied whether O3-induced pulmonary function decrements could be inhibited by the prostaglandin synthetase inhibitor, indomethacin, in healthy human subjects. Fourteen college-age males completed six 1-h exposure protocols consisting of no drug, placebo, and indomethacin (Indocin SR 75 mg every 12 h for 5 days) pretreatments, with filtered air and O3 (0.35 ppm) exposures within each pretreatment. Pretreatments were delivered weekly in random order in a double-blind fashion. Ozone and filtered air exposures, separated by 72 h, were delivered in random order in a single-blind fashion. Exposures consisted of 1-h exercise on a bicycle ergometer with work loads set to elicit a mean minute ventilation of 60 L/min. Statistical analysis revealed significant (p < 0.05) across pretreatment effects for FVC and FEV1, with no drug versus indomethacin and placebo versus indomethacin comparisons being significant. These findings suggest that cyclooxygenase products of arachidonic acid, which are sensitive to indomethacin inhibition, play a prominent role in the development of pulmonary function decrements consequent to acute O3 exposure.",
author = "Schelegle, {Edward S} and Adams, {W. C.} and Siefkin, {A. D.}",
year = "1987",
language = "English (US)",
volume = "136",
pages = "1350--1354",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects

AU - Schelegle, Edward S

AU - Adams, W. C.

AU - Siefkin, A. D.

PY - 1987

Y1 - 1987

N2 - We studied whether O3-induced pulmonary function decrements could be inhibited by the prostaglandin synthetase inhibitor, indomethacin, in healthy human subjects. Fourteen college-age males completed six 1-h exposure protocols consisting of no drug, placebo, and indomethacin (Indocin SR 75 mg every 12 h for 5 days) pretreatments, with filtered air and O3 (0.35 ppm) exposures within each pretreatment. Pretreatments were delivered weekly in random order in a double-blind fashion. Ozone and filtered air exposures, separated by 72 h, were delivered in random order in a single-blind fashion. Exposures consisted of 1-h exercise on a bicycle ergometer with work loads set to elicit a mean minute ventilation of 60 L/min. Statistical analysis revealed significant (p < 0.05) across pretreatment effects for FVC and FEV1, with no drug versus indomethacin and placebo versus indomethacin comparisons being significant. These findings suggest that cyclooxygenase products of arachidonic acid, which are sensitive to indomethacin inhibition, play a prominent role in the development of pulmonary function decrements consequent to acute O3 exposure.

AB - We studied whether O3-induced pulmonary function decrements could be inhibited by the prostaglandin synthetase inhibitor, indomethacin, in healthy human subjects. Fourteen college-age males completed six 1-h exposure protocols consisting of no drug, placebo, and indomethacin (Indocin SR 75 mg every 12 h for 5 days) pretreatments, with filtered air and O3 (0.35 ppm) exposures within each pretreatment. Pretreatments were delivered weekly in random order in a double-blind fashion. Ozone and filtered air exposures, separated by 72 h, were delivered in random order in a single-blind fashion. Exposures consisted of 1-h exercise on a bicycle ergometer with work loads set to elicit a mean minute ventilation of 60 L/min. Statistical analysis revealed significant (p < 0.05) across pretreatment effects for FVC and FEV1, with no drug versus indomethacin and placebo versus indomethacin comparisons being significant. These findings suggest that cyclooxygenase products of arachidonic acid, which are sensitive to indomethacin inhibition, play a prominent role in the development of pulmonary function decrements consequent to acute O3 exposure.

UR - http://www.scopus.com/inward/record.url?scp=0023629873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023629873&partnerID=8YFLogxK

M3 - Article

C2 - 3688637

AN - SCOPUS:0023629873

VL - 136

SP - 1350

EP - 1354

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -